PMID: 9057784Feb 1, 1997Paper

Pharmacogenetics in pediatrics. Implications for practice

Pediatric Clinics of North America
J S Leeder, G Kearns


Cumulative experience with pharmacotherapy in children indicates that it is difficult to prescribe medications rationally solely on the basis of patient age. Furthermore, the apparent drug biotransformation phenotype may be influenced by disease (e.g., infection), environmental factors (e.g., diet and environmental contaminants), and concurrent medications. Therefore, characterization of drug biotransformation pathways during development and, at a given developmental stage, the effects of known modulators of drug biotransformation are essential for optimum treatment. This is particularly true when one considers that altered drug biotransformation may contribute significantly to therapeutic failure (e.g., graft rejection with inadequate serum and tissue concentrations of cyclosporin and myelotoxicity consequent to a relative inability to metabolize normal doses of certain antineoplastic agents). Accordingly, the goals of coordinated clinical and basic investigations should be to characterize important drug biotransformation pathways for compounds under development and intended for use in pediatrics and to identify the population extremes or "outliers" to aid in selection of an appropriate dosage range for efficacy studies. Acqui...Continue Reading


Jan 1, 1992·Critical Reviews in Toxicology·S A Wrighton, J C Stevens
Dec 5, 1991·European Journal of Biochemistry·Jean-Marc TréluyerT Cresteil
Sep 1, 1991·British Journal of Clinical Pharmacology·M G LadonaA Rane
May 1, 1991·Pediatric Research·A Pariente-KhayatG Olive
Jan 1, 1990·Progress in Liver Diseases·U A MeyerM Blum
Jan 1, 1990·Pharmacology & Therapeutics·M Eichelbaum, A S Gross
Jan 1, 1990·European Journal of Clinical Pharmacology·E HadasováE Kadlcáková
Jan 1, 1989·Archives of Biochemistry and Biophysics·S A Wrighton, M VandenBranden
Oct 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J SeidegårdW R Pearson
Jan 1, 1987·Epilepsia·W E Dodson
Sep 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·P B WatkinsP S Guzelian
Jul 17, 1995·Biochemical Pharmacology·Z Y Zhang, L S Kaminsky
Aug 16, 1995·Biochimica Et Biophysica Acta·K LundströmI Ulmanen
Dec 1, 1994·Pharmacogenetics·J A Goldstein, S M de Morais
Feb 1, 1995·Pharmacogenetics·K P VatsisM V Relling
Nov 10, 1994·The New England Journal of Medicine·J C Roujeau, R S Stern
Sep 1, 1994·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·M J Rieder
Feb 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·E Y KrynetskiWilliam E Evans
Oct 1, 1994·Pharmacogenetics·J C KolarsP B Watkins
Sep 1, 1994·Journal of Clinical Pharmacology·D G May
Aug 1, 1994·Pharmacogenetics·P B Watkins
Feb 1, 1994·Pharmacogenetics·Allan E RettieK R Korzekwa
May 1, 1994·British Journal of Clinical Pharmacology·C CazeneuveG Olive
Feb 22, 1994·Biochemistry·J A GoldsteinB I Ghanayem
Feb 1, 1993·Pharmacogenetics·F J GonzalezM Yano
Mar 1, 1996·The American Journal of Psychiatry·C B NemeroffB G Pollock
Jun 1, 1996·Pharmacogenetics·A K DalyU M Zanger
Aug 1, 1996·Pharmacogenetics·T H Sullivan-KloseJ A Goldstein


Apr 29, 1998·Journal of Clinical Pharmacology·G KearnsJ L Blumer
Dec 12, 2007·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Jennifer A LowryAnthony J Scalzo
Dec 31, 2009·European Journal of Clinical Pharmacology·Maria José Solana, Jesús López-Herce
Aug 26, 2006·Pediatric Cardiology·Brady S Moffett, Anthony C Chang
Jun 19, 2001·Primary Care·S Chaffee
Nov 13, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·M Catalano
Oct 7, 2004·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Elke De WachterJean De Schepper
Mar 5, 2002·British Journal of Clinical Pharmacology·C BrazellM Mosteller
Sep 13, 2001·Alimentary Pharmacology & Therapeutics·C FaureE Jacoz-Aigrain
Mar 6, 2002·Clinical and Experimental Immunology·S D LyttonM Ingelman-Sundberg
Mar 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yi-Shin HuangShou-Dong Lee
Jan 20, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·L G CohenJ G Flood
Nov 28, 2002·Journal of Clinical Psychopharmacology·T WilensVikram Sinha
Jan 6, 2001·The Pediatric Infectious Disease Journal·G KearnsPediatric Pharmacology Research Unit Network
Feb 27, 2001·The Pediatric Infectious Disease Journal·J A LowryG Kearns
Jan 11, 2003·American Journal of Therapeutics·Joseph Prandota
Aug 1, 1998·Inflammatory Bowel Diseases·G Kearns
Dec 2, 2004·Pediatric Emergency Care·Antonio E MuñizRobin L Foster
Dec 17, 2005·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Esi M DeWittRandy Q Cron
May 13, 2009·American Journal of Therapeutics·Joseph Prandota
Oct 20, 2010·Antimicrobial Agents and Chemotherapy·Sihem BenaboudTEmAA ANRS 12109 Study Group
Sep 4, 2012·Tobacco Control·Erika Avila-TangStephen S Hecht
Jan 5, 2002·Journal of Clinical Pharmacology·M D ReedPediatric Pharmacology Research Unit Network
May 5, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gareth J VealClinton F Stewart
May 6, 2005·Clinical Pharmacokinetics·Catherine LitalienChristophe Faure
May 9, 2014·Cardiovascular Toxicology·Nikki Gillum Posnack
Jun 28, 2006·Journal of Perinatology : Official Journal of the California Perinatal Association·R M WardK H Albertine
Jun 12, 2012·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Diana GuimarãesJosé Paulo Santos
Apr 9, 2008·International Journal of Radiation Oncology, Biology, Physics·Chiaho HuaThomas E Merchant
Sep 5, 2003·Journal of Clinical Pharmacology·G KearnsJohn N van den Anker
Jul 28, 2012·Acta Anaesthesiologica Scandinavica·S LundebergS Eksborg
May 12, 2004·Regulatory Toxicology and Pharmacology : RTP·L L de ZwartA J A M Sips
Mar 22, 2006·Seminars in Perinatology·Robert M Ward
Nov 13, 2007·Journal of Applied Toxicology : JAT·Parvaneh EspandiariJoseph P Hanig
Oct 21, 2009·Acta Anaesthesiologica Scandinavica·S LundebergS Eksborg
Feb 14, 2015·British Journal of Clinical Pharmacology·A R Kreeftmeijer-VegterP J de Vries
Aug 9, 2003·Expert Opinion on Drug Safety·Douglas L Blowey
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Uwe ChristiansManuel Haschke
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·M Strolin BenedettiE L Baltes
Nov 6, 2013·Advanced Drug Delivery Reviews·Hannah K BatchelorSandra Klein
Apr 4, 2015·Pediatric Clinics of North America·Robert M WardKaren Buchi
Oct 31, 2008·Clinical Pharmacology and Therapeutics·Mj Kennedy
Sep 13, 2016·International Journal of Molecular Sciences·Vid MlakarMarc Ansari
Mar 23, 2017·Acta Paediatrica·Antal Németh
Nov 22, 2008·Toxicology and Industrial Health·S WilburO Faroon
Apr 7, 2000·Clinical Pediatrics·G KearnsG S Wasserman
May 10, 2018·Pediatric Blood & Cancer·Jessica HochbergMitchell S Cairo
Nov 26, 2008·Toxicology and Industrial Health·O FaroonD J Plewak
Apr 4, 2006·Current Opinion in Rheumatology·Stacy P Ardoin, John S Sundy
Apr 20, 2012·Critical Reviews in Toxicology·Shakil Ahmed SaghirAlene Theresa McCoy
Mar 19, 1999·Proceedings. Biological Sciences·T von SchantzH Wittzell
Jun 3, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hao-Jie ZhuJohn S Markowitz
Nov 28, 2019·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Michelle KnechtChristy Mumphrey
Oct 23, 2004·Drug Metabolism and Pharmacokinetics·Shogo OzawaJun-Ichi Sawada
Oct 4, 2019·Scientific Reports·Anca Rădulescu, Steven Lundgren
May 18, 1999·Journal of Pediatric Gastroenterology and Nutrition·R J ShulmanG Van Hare
Oct 30, 1999·Antimicrobial Agents and Chemotherapy·M MirochnickJ McNamara
Dec 29, 2000·Annals of the New York Academy of Sciences·M Mirochnick
Jan 7, 2003·Paediatric Drugs·Troy E Gibbons, Benjamin D Gold
May 27, 2003·Paediatric Drugs·Katherine A Lyseng-Williamson, Karen L Goa
Jun 30, 2019·Circulation. Arrhythmia and Electrophysiology·Louise ReillyLee L Eckhardt
Sep 11, 2019·Journal of Clinical Pharmacology·Dionna Green
Sep 26, 2020·Annual Review of Pharmacology and Toxicology·Abdelbaset A ElzagallaaiMichael J Rieder
Jan 13, 2018·Current Problems in Pediatric and Adolescent Health Care·Anna M WehryJeffrey R Strawn

Related Concepts

Metabolic Biotransformation
Infant Development
Cytochrome P-450 Oxygenase
Drug Interactions
Pharmaceutical Preparations
Pediatric Discipline

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.